HCP engagement starts with the right data—and physician-level data (PLD) is the powerhouse behind smarter segmentation and campaign optimization. Whether you're just getting started or leveling up, our guide has you covered.
Activating Intelligence: Getting More from Your PLD Today—and Tomorrow
Activating Intelligence: Getting More from Your PLD Today—and Tomorrow
HCP engagement starts with the right data—and physician-level data (PLD) is the powerhouse behind smarter segmentation and campaign optimization. Whether you're just getting started or leveling up, our guide has you covered.
Ideas, Insights, and Inspiration for Modern Healthcare Marketers
Explore our full library of resources developed by healthcare industry leaders aimed to spark actionable ideas.
Let's Talk
Want patients and providers talking about your brand? Talk to us first.
All Resources
29 results found
Unleashing the Power of Machine Learning for Personalized Engagement
In today's digital landscape, capturing and retaining consumer attention has become an uphill battle. With over $1.1 billion spent monthly on pharmaceutical...
AI Isn’t Enough: Human Intelligence Is Still Key in Pharma Marketing
It can feel like we are drowning in companies pushing AI capabilities or embedding AI in their apps, and that’s just what we see on the surface. Our reactions...
Patient-First Engagement: Navigating Privacy-Conscious Era
The healthcare industry thrives on innovation, and that includes the way it reaches patients. Traditionally, pharmaceutical marketers targeted patients via...
Four Red Flags to Watch for in Your Pharma Marketing
In the excitement that follows every new trend in pharmaceutical marketing, it’s easy to lose sight of the bedrock principles that drive impact and ROI. Here...
2024 Pharma Marketing: Improved Execution Through Data and Technology
The past few years have been a whirlwind for pharma marketing. AI, real-world data, and omnichannel strategies have exploded, transforming how we reach doctors...
OptimizeRx + Medicx: Looking Ahead to Better Pharmaceutical Marketing
The end of the year is often a time for reflection, as we think back on our experiences, learnings, successes, and setbacks. But it’s also an occasion to...
Next-Best Action: Elevating the Future of Omnichannel HCP Marketing
Terms like omnichannel, artificial intelligence (AI), data-driven, and real time are defining the conversation around HCP marketing – and for good reason....
Supporting HCPs with EHR Software Solutions
Life science manufacturers’ interest in EHR-based solutions for HCP engagement is growing, but the recent and rapid growth in the market means that navigating...
HCP Engagement and the Sales Rep: Enabling Face-to-Face Connections
HCP Engagement in the Digital Marketing Era Sales representatives have long been a vital ingredient in life science companies' HCP engagement strategies –...
Advancing Omnichannel Marketing with Real-World Data
Unlocking the Full Potential of Real-World Data Real-World Data (RWD) has become an integral, inseparable element of omnichannel marketing (OCM), which is an...
Benchmark Your Market Access Digital Maturity
When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your...
Strengthening HCP Engagement with Omnichannel Strategies
During the recent Digital Pharma Innovation Week, I had the great opportunity to lead a roundtable discussion with a group of stakeholders from across the...
Making the Case for a Digital Revolution in Market Access
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution....
Predicting Patient Adherence Threats with AI-Driven Brand Solutions
Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans,...
Physician Survey: Access Pathways, Patient Care and the Implications for Pharma
There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications. OptimizeRx surveyed 100+...
A Digital Point-of-Care Primer for Life Science Marketers
Growth in healthcare technology began with the HITECH (Health Information Technology for Economic and Clinical Health) Act of 2009 and has grown significantly...
Predictive Patient Discovery Prior to Therapy Changes with AI+RWD
Every day, patients switch to new therapies because of disease progression, side effects, affordability or other factors—potentially delaying patient...
The RWD Win/Win: A Strategy that Delivers for Pharma, Patients, HCPs and More
Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re...
Reducing Misdiagnosis with AI-Driven Patient Journey Mapping
It’s a problem with an enormous impact on patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been...
A Data-Driven Approach that Improves Patient Care Journeys
Offering a Practical Approach to AI and Real World Data Despite incredible advances in the availability of real-world data (RWD) and AI applications, many...
HCP Targeting: Be there when your ideal patient and provider meet
Unlocking the Full Potential with Artificial Intelligence in Pharma Marketing At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to...
Key Themes from Overcoming Challenges in Multiple Sclerosis Treatment
Key Themes and Takeways from Our Multiple Sclerosis Series In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored...
Overcoming Patient Adherence Challenges in Multiple Sclerosis Treatment
Part Three of Our Multiple Sclerosis Series In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to...
Overcoming Initiation Challenges in Multiple Sclerosis Treatment
Part Two of Our Multiple Sclerosis Series In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier,...
Overcoming Awareness Challenges in Multiple Sclerosis Treatment
Introducing a New Series on Multiple Sclerosis When it comes to multiple sclerosis (MS), there are multiple challenges that can deter patients from receiving...
Omnichannel Strategy Insights from Digital Pharma East 2021
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies...
Advancing Oncology Treatment and Health Equity – An ASCO Recap
The annual meeting of the American Society of Clinical Oncology (ASCO) was held last month and I am excited to share with you my thoughts on the highlights...
The 6th “R” in Medication Administration
Like any prescribing HCP, I, as a nurse practitioner, recognized that making medication decisions was one of the biggest choices I had to make for patients. My...
OptimizeRx Specialty Solutions: Technology that Optimizes Your Access Support Ecosystem
As a scientist, I know first-hand how much time and energy go into the drug discovery and development process from day one. In fact, one of the highlights of...